KS
Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
$25.77 +0.00% (+$0.00)
Market Cap ¥168.1B
P/E Ratio 11.99x
Div. Yield 4.01%
ROE 6.32%
Bulios Fair Price
$34.98
35.7% upside
Current Price
$25.77
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KSPHF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
84 /100
Cheap P/S 1.70x
P/E 11.99x
P/B 0.74x
Growth
45 /100
Stable Book val. growth 1.25%
EPS growth 0.72%
Rev. growth 10.55%
Profitability
37 /100
Moderate Op. margin 4.11%
Gross margin 46.82%
FCF margin 0.00%
Quality
21 /100
Poor ROA 5.22%
ROIC 1.32%
Asset turnover 0.37x
Debt
100 /100
Low Int. coverage 324.82x
Debt/Equity 0.01x
Net debt/EBITDA -1.98x
Stability
85 /100
Stable EPS volatility 16.32%
Beta 0.38x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KSPHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mutsuo Kanzawa
Employees
1,786
Headquarters
Matsumoto
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
10 NOV
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date